Gaspari Nutrition

DTN8

Serving

1 Capsule(s)

Per container

Form

capsule-unknown

UPC

646511026537

DSLD

291998

Formula hash

89ebe0425be1

Brand context

Gaspari Nutrition

Catalog

315

products

With avoid flag

products

FDA recalls

history

CAERS

reports

Caution-flaggedObjective label signals

Flagged excipients

0 avoid · 2 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

2 excipients carry authority-caution citations. · Every flag below links to the authority's published citation.

Supplement Facts

4 active ingredients

Ingredient	Amount	% DV
Vitamin B6 vitaminUNII · KV2JZ1BI6Z UL · set6 effects	2 mg	100%
Chromium Picolinate Chomium picolinatemineralUNII · S71T8B8Z6P	200 mcg	167%
Super Energy & Thermo Blend Blendother	1002 mg	—
Stress & Cortisol Control Blend Blendother	300 mg	—

What this product supports · authorized claims

6 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

↑Normal energy-yielding metabolism
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-75 →
↑Normal nervous system function
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-66 →
↑Normal immune system function
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-73 →
↑Normal formation of red blood cells + hemoglobin
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-67 →LOINC 789-8
↓Normal homocysteine metabolism
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-77 →LOINC 13965-9
↓Reduction of tiredness and fatigue
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-78 →

Flagged excipients

2 flagged · authority citations

◐ CAUTIONFD&C Red #40
color
EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).
eur-lex.europa.eu →leginfo.legislature.ca.gov →
◐ CAUTIONFD&C Yellow #5
color
EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).
eur-lex.europa.eu →ecfr.gov →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Pearlescent Pigment · Magnesium Stearate · Silicon Dioxide